Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
May 16, 2024 16:05 ET
|
Amwell
Boston, May 16, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO and President, Roy Schoenberg, M.D., M.P.H., will speak at the...
Rapid7 to Attend Upcoming Investor Conferences
May 16, 2024 16:05 ET
|
Rapid7
BOSTON, May 16, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: ...
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
May 16, 2024 16:05 ET
|
PowerUp Acquisition Corp.
New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”), which...
Epsilon Announces 2024 AGM Results
May 16, 2024 16:05 ET
|
Epsilon Energy Ltd.
HOUSTON, May 16, 2024 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) is pleased to announce that all the nominees listed in its Proxy Statement, Schedule 14A...
TEN Ltd. Announces Delivery of Six Environmentally Friendly Vessels Since the Beginning of 2024
May 16, 2024 16:05 ET
|
Tsakos Energy Navigation
Green-growth initiative program in progress Strong tanker market fundamentals ATHENS, Greece, May 16, 2024 (GLOBE NEWSWIRE) -- TEN, Ltd (NYSE: TNP) (the “Company”) announces that following the...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2024 16:05 ET
|
Annexon Biosciences
BRISBANE, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living...
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
May 16, 2024 16:05 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial...
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
May 16, 2024 16:05 ET
|
Myriad Genetics, Inc.
Myriad’s Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY, May 16, 2024 (GLOBE NEWSWIRE) -- Myriad...
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
May 16, 2024 16:05 ET
|
Spero Therapeutics, Inc.
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel...
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
May 16, 2024 16:05 ET
|
Roivant Sciences
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday,...
- May 16, 2024 16:15 ET Robbins LLP Reminds Investors of AKRO of the Pending Lead Plaintiff Deadline in the Akero Therapeutics, Inc. Class Action
- May 16, 2024 16:05 ET Fortrea Appoints Machelle Sanders to Board of Directors